De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Regis Healthcare Beheer

Beheer criteriumcontroles 3/4

De CEO Regis Healthcare's is Linda Mellors, benoemd in Sep2019, heeft een ambtstermijn van 5.08 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 1.66M, bestaande uit 47.5% salaris en 52.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.094% van de aandelen van het bedrijf, ter waarde A$ 1.77M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4 jaar en 6.6 jaar.

Belangrijke informatie

Linda Mellors

Algemeen directeur

AU$1.7m

Totale compensatie

Percentage CEO-salaris	47.5%
Dienstverband CEO	5.1yrs
Eigendom CEO	0.09%
Management gemiddelde ambtstermijn	4yrs
Gemiddelde ambtstermijn bestuur	6.6yrs

Recente managementupdates

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18

Recent updates

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Sep 12

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02

Analyse CEO-vergoeding

Hoe is Linda Mellors's beloning veranderd ten opzichte van Regis Healthcare's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$2m	AU$789k	-AU$21m
Mar 31 2024	n/a	n/a	-AU$18m
Dec 31 2023	n/a	n/a	-AU$15m
Sep 30 2023	n/a	n/a	-AU$22m
Jun 30 2023	AU$1m	AU$755k	-AU$28m
Mar 31 2023	n/a	n/a	-AU$45m
Dec 31 2022	n/a	n/a	-AU$61m
Sep 30 2022	n/a	n/a	-AU$50m
Jun 30 2022	AU$952k	AU$711k	-AU$39m
Mar 31 2022	n/a	n/a	-AU$16m
Dec 31 2021	n/a	n/a	AU$8m
Sep 30 2021	n/a	n/a	AU$14m
Jun 30 2021	AU$767k	AU$698k	AU$20m
Mar 31 2021	n/a	n/a	AU$8m
Dec 31 2020	n/a	n/a	-AU$4m
Sep 30 2020	n/a	n/a	-AU$2m
Jun 30 2020	AU$729k	AU$643k	-AU$716k

Compensatie versus markt: De totale vergoeding ($USD 1.14M ) Linda } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 1.47M ).

Compensatie versus inkomsten: De vergoeding van Linda is gestegen terwijl het bedrijf verliesgevend is.

CEO

Linda Mellors

5.1yrs

Tenure

AU$1,661,446

Compensatie

Dr. Linda Jane Mellors, B.A., B.Sc. (Hons), Ph.D. (Med) GAICD, Grad Cert HSM, has been Chief Executive Officer of Regis Healthcare Limited since September 4, 2019 and serves as its Managing Director and Di...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Linda Mellors	CEO, MD & Director	5.1yrs	AU$1.66m	0.094% A$ 1.8m
Rick Rostolis	Chief Financial Officer	4.6yrs	AU$1.19m	0.028% A$ 527.9k
Imtiaz Bhayat	Chief Information Officer	4yrs	geen gegevens	geen gegevens
Malcolm Ross	General Counsel & Company Secretary	2.9yrs	geen gegevens	geen gegevens
Carolyn Noumertzis	Chief People Officer	1.9yrs	geen gegevens	geen gegevens

4.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van REG wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Linda Mellors	CEO, MD & Director	5.1yrs	AU$1.66m	0.094% A$ 1.8m
Graham Hodges	Independent Non-Executive Chairman	7.2yrs	AU$289.23k	0.037% A$ 700.6k
Christine Bennett	Independent Non-Executive Director	6.6yrs	AU$189.23k	0.027% A$ 525.6k
Ian Roberts	Non-Executive Director	10yrs	AU$169.23k	27.2% A$ 521.9m
Bryan Dorman	Non-Executive Director	10yrs	AU$154.62k	21.38% A$ 410.3m
Jodie Leonard	Independent Non-Executive Director	less than a year	AU$97.69k	0.0045% A$ 86.0k
Sally Freeman	Independent Non-Executive Director	2.8yrs	AU$189.23k	0.010% A$ 191.1k

6.6yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van REG wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.6 jaar).

Regis Healthcare Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Regis Healthcare Limited, Annual General Meeting, Nov 26, 2024

Non-Executive Director recently sold AU$68m worth of stock

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Regis Healthcare Limited Announces the Resignation of Rebecca Dean as Company Secretary

Recent updates

Regis Healthcare Limited, Annual General Meeting, Nov 26, 2024

Regis Healthcare Limited (ASX:REG) agreed to acquire Two residential aged care homes in Capel Sound and Mornington from Ti Tree Operations Pty Ltd for AUD 35.5 million.

Regis Healthcare Limited's (ASX:REG) P/S Is Still On The Mark Following 31% Share Price Bounce

Final dividend of AU$0.066 announced

Price target increased by 7.5% to AU$4.74

Full year 2024 earnings: Revenues exceed analyst expectations

Regis Healthcare Limited to Report Second Half, 2024 Results on Aug 26, 2024

Price target increased by 8.5% to AU$4.37

Non-Executive Director recently sold AU$68m worth of stock

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Upcoming dividend of AU$0.063 per share

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

First half dividend increased to AU$0.063

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited (ASX:REG) agreed to acquire Cpsm Pty Ltd for AUD 74.2 million.

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Price target increased by 8.7% to AU$2.74

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased by 8.8% to AU$2.59

Upcoming dividend of AU$0.075 per share at 3.8% yield

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Consensus EPS estimates fall by 14%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on September 27, 2023

Regis Healthcare Limited Announces the Resignation of Rebecca Dean as Company Secretary

Regis Healthcare Limited, Annual General Meeting, Oct 24, 2023

Regis Healthcare Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

Price target increased by 7.6% to AU$2.33

Consensus EPS estimates fall by 18%

Upcoming dividend of AU$0.02 per share at 3.7% yield

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: AU$0.086 loss per share (vs AU$0.012 loss in 1H 2022)

Regis Healthcare Limited to Report First Half, 2023 Results on Feb 24, 2023

Consensus forecasts updated

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Upcoming dividend of AU$0.023 per share

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Fiscal Year 2022 Final Dividend, Payable on September 30, 2022

Regis Healthcare Limited, Annual General Meeting, Oct 25, 2022

Consensus forecasts updated

Consensus forecasts updated

Regis Healthcare Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Now 21% undervalued

Consensus forecasts updated

Upcoming dividend of AU$0.035 per share

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Declares Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on April 8, 2022

Upcoming dividend of AU$0.046 per share

Full year 2021 earnings released

Price target increased to AU$2.49

Consensus forecasts updated

Insufficient new directors

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

Price target increased to AU$2.22

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

Regis Healthcare Limited to Report Fiscal Year 2021 Results on Aug 31, 2021

Regis Healthcare Limited, Annual General Meeting, Oct 26, 2021

Regis Healthcare Limited to Report First Half, 2021 Results on Feb 24, 2021

Washington H. Soul Pattinson and Company Limited and Ashburn Pty Limited cancelled the acquisition of the remaining 72.76% stake in Regis Healthcare Limited (ASX:REG) from Bryan Dorman and others.